Smallpox and Monkeypox vaccine, JYNNEOS™, receives FDA approval

Bavarian Nordic A/S today announced that the U.S. Food and Drug Administration (FDA) has approved JYNNEOSa (Smallpox and Monkeypox Vaccine, Live, Non-replicating) (MVA-BN(R), liquid-frozen) for prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection. JYNNEOS is the only approved ["]

The post Smallpox and Monkeypox vaccine, JYNNEOSa, receives FDA approval appeared first on Outbreak News Today.